Angeliki Stamtsis-Datsi

6PUBLICATIONS
40CO-AUTHORS
Molecular targetsAutonomic nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNanoelectromechanical systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 19, 2026
Cellular immunotherapy in melanoma: the next frontier in cancer treatment.

|Nov 14, 2025
The Neurogenic Inflammation Mediator Endothelin-1 Causes Human Skin Barrier Disruption in Atopic Dermatitis via an ETAR/TRPA1-Axis.

Rari Leo, Anh Jochebeth, Nabeel Abdulrahman

|Mar 13, 2025
Immune Cell Interplay in the Fight Against GBM.

Nico Vallieri, Angeliki Datsi

|Apr 12, 2023
Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer.

Stefan Naulaerts, Angeliki Datsi, Daniel M Borras

|Mar 10, 2022
Impaired p53-Mediated DNA Damage Response Contributes to Microcephaly in Nijmegen Breakage Syndrome Patient-Derived Cerebral Organoids.

Soraia Martins, Lars Erichsen, Angeliki Datsi

|Feb 25, 2021
Interleukin-31: The "itchy" cytokine in inflammation and therapy.

Angeliki Datsi, Martin Steinhoff, Fareed Ahmad

Pageof 1

Frequent Collaborators

2 joint publications

Martin Steinhoff

2 joint publications

Fareed Ahmad

2 joint publications

Majid Alam

2 joint publications

Joerg Buddenkotte